Úplné zobrazení záznamu

Toto je statický export z katalogu ze dne 04.06.2026. Zobrazit aktuální podobu v katalogu.

Bibliografická citace

.
0 (hodnocen0 x )
EB
ONLINE
Hauppauge, N.Y. : Nova Science, c2011
1 online resource (ix, 182 p.) : ill
Externí odkaz    Plný text PDF 
   * Návod pro vzdálený přístup 


ISBN 9781621004394 (electronic bk.)
ISBN 9781612093949 (hardcover)
Business issues, competition and entrepreneurship
Pharmacology-research, safety testing and regulation
Includes bibliographical references and index
Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA’s authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO.
Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries
001800768
full
(Au-PeEL)EBL3021409
(CaPaEBR)ebr10683067
(MiAaPQ)EBC3021409
(OCoLC)750642412

Zvolte formát: Standardní formát Katalogizační záznam Zkrácený záznam S textovými návěštími S kódy polí MARC